Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous fMRI/EEG of the 4 mg nicotine lozenge in relief of cognitive impairment associated with nicotine withdrawal
2007-002374-55Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing 4 mg nicotine lozenge with Placebo lozenge (2 arms). Primary endpoint: BOLD activation associated with attention. Started Jul 2007; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2007-002374-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002374-55.